Plain-English translation of NCT06113913 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing (a medication that helps calm the immune system in inflammatory bowel disease) given as weekly versus every-other-week injections under the skin. You would be eligible if you've been doing well on intravenous and your doctor thinks you're ready to switch to self-injections at home.
Many patients with inflammatory bowel disease do well on this medication, but the intravenous form requires clinic visits every few weeks. This trial is trying to figure out whether a less frequent injection schedule (every other week instead of weekly) works just as well, which could make life easier for patients.
You likely qualify if…
You likely don't qualify if…
You would switch from visiting a clinic for intravenous infusions to giving yourself injections at home. Depending on which group you're randomly assigned to, you would either inject the medication every week or every other week. The trial will monitor how well you do over time with blood tests and check-ins, and compare whether both schedules keep you in remission equally well.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Belgium